Literature DB >> 3993694

The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects.

M G Aman, N N Singh, A W Stewart, C J Field.   

Abstract

The development of a scale to assess drug and other treatment effects on severely mentally retarded individuals was described. In the first stage of the project, an initial scale encompassing a large number of behavior problems was used to rate 418 residents. The scale was then reduced to an intermediate version, and in the second stage, 509 moderately to profoundly retarded individuals were rated. Separate factor analyses of the data from the two samples resulted in a five-factor scale comprising 58 items. The factors of the Aberrant Behavior Checklist have been labeled as follows: (I) Irritability, Agitation, Crying; (II) Lethargy, Social Withdrawal; (III) Stereotypic Behavior; (IV) Hyperactivity, Noncompliance; and (V) Inappropriate Speech. Average subscale scores were presented for the instrument, and the results were compared with empirically derived rating scales of childhood psychopathology and with factor analytic work in the field of mental retardation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3993694

Source DB:  PubMed          Journal:  Am J Ment Defic        ISSN: 0002-9351


  378 in total

1.  Brief report: six months continuation treatment in naltrexone-responsive children with autism: an open-label case-control design.

Authors:  S H Willemsen-Swinkels; J K Buitelaar; I A van Berckelaer-Onnes; H van Engeland
Journal:  J Autism Dev Disord       Date:  1999-04

Review 2.  The pathophysiology and treatment of autism.

Authors:  D J Posey; C J McDougle
Journal:  Curr Psychiatry Rep       Date:  2001-04       Impact factor: 5.285

3.  Exploration of psychometric properties of the developmental behavior checklist.

Authors:  R P Hastings; T Brown; R H Mount; K F Cormack
Journal:  J Autism Dev Disord       Date:  2001-08

Review 4.  Assessment in multisite randomized clinical trials of patients with autistic disorder: the Autism RUPP Network. Research Units on Pediatric Psychopharmacology.

Authors:  L E Arnold; M G Aman; A Martin; A Collier-Crespin; B Vitiello; E Tierney; R Asarnow; F Bell-Bradshaw; B J Freeman; P Gates-Ulanet; A Klin; J T McCracken; C J McDougle; J J McGough; D J Posey; L Scahill; N B Swiezy; L Ritz; F Volkmar
Journal:  J Autism Dev Disord       Date:  2000-04

5.  Assessing emotional and behavioral problems in children with intellectual disability: revisiting the factor structure of the developmental behavior checklist.

Authors:  Marielle C Dekker; Russell J Nunn; Stewart E Einfeld; Bruce J Tonge; Hans M Koot
Journal:  J Autism Dev Disord       Date:  2002-12

6.  Characterization of Medication Use in a Multicenter Sample of Pediatric Inpatients with Autism Spectrum Disorder.

Authors:  Logan K Wink; Ernest V Pedapati; Ryan Adams; Craig A Erickson; Kahsi A Pedersen; Eric M Morrow; Desmond Kaplan; Matthew Siegel
Journal:  J Autism Dev Disord       Date:  2018-11

7.  The Cost of Raising Individuals with Fragile X or Chromosome 15 Imprinting Disorders in Australia.

Authors:  Emma K Baker; Sheena Arora; David J Amor; Perrin Date; Meagan Cross; James O'Brien; Chloe Simons; Carolyn Rogers; Stephen Goodall; Jennie Slee; Chris Cahir; David E Godler
Journal:  J Autism Dev Disord       Date:  2021-07-22

8.  Behavioral Phenotype of ASD Preschoolers with Gastrointestinal Symptoms or Food Selectivity.

Authors:  Margherita Prosperi; Elisa Santocchi; Giulia Balboni; Antonio Narzisi; Margherita Bozza; Francesca Fulceri; Fabio Apicella; Roberta Igliozzi; Angela Cosenza; Raffaella Tancredi; Sara Calderoni; Filippo Muratori
Journal:  J Autism Dev Disord       Date:  2017-11

9.  Pitolisant in an Adolescent with Prader-Willi Syndrome.

Authors:  Stephanie Pennington; Danielle Stutzman; Elise Sannar
Journal:  J Pediatr Pharmacol Ther       Date:  2021-05-19

10.  Fluoxetine in treatment of adolescent patients with autism: a longitudinal open trial.

Authors:  S H Fatemi; G M Realmuto; L Khan; P Thuras
Journal:  J Autism Dev Disord       Date:  1998-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.